From BioHealth Investor
Biotechnology
FERMAVIR PHARMACEUTL [FMVR.OB] +17.60%
OBAGI MEDICAL [OMPI] +8.72%
XTL BIOPHARMACEUTICA [XTLB] +7.31%
CYTORI THERAPEUTICS [CYTX] +7.16%
MEMORY PHARMACEUTICA [MEMY] +4.64%
Diagnostic Substances
AVALON PHARMACEUTIC [AVRX] +4.60%
ICAGEN, INC. [ICGN] +3.70%
PRESSURE BIOSCIENC [PBIO] +2.50%
COLEY PHARMACEUTICAL [COLY] +1.76%
ASPENBIO PHARMA INC [APNB.OB] +1.69%
Drug Delivery
ALKERMES INC [ALKS] +2.81%
IOMED INC [IOX] +2.44%
K V PHARMA CL A [KV-A] +1.83%
BIOPROGRESS PLC [BPRG] +1.79%
HOSPIRA INC [HSP] +1.09%
Drug Manufacturers
REGENERX BIOPHARM IN [RGN] +5.36%
KENDLE INTL INC [KNDL] +2.93%
GENTIUM SPA ADS [GENT] +2.09%
MGI PHARMA INC [MOGN] +1.88%
INYX INC [IYXI.OB] +1.33%
Medical Appliances & Equipment
RESPIRONICS INC [RESP] +11.36%
CAMBRIDGE HEART INC [CAMH.OB] +5.74%
SYNOVIS LIFE TECH [SYNO] +4.90%
TRIMEDYNE INC [TMED.OB] +4.44%
CARDIODYNAMICS INT [CDIC] +3.45%
Medical Instruments & Supplies
MILESTONE SCIENTIFIC [MLSS.OB] +12.58%
BIOMIMETIC THERAPEUT [BMTI] +8.46%
NEPHROS INC. [NEP] +5.57%
EP MEDSYSTEMS INC [EPMD] +4.55%
ANGIODYNAMICS INC [ANGO] +3.04%
Medical Laboratories & Research
PREMD INC [PME] +4.11%
NEOGENOMICS INC [NGNM.OB] +1.25%
QUEST DIAGNOSTC [DGX] +0.47%
ENZO BIOCHEM INC [ENZ] +0.33%
NATL DENTEX CP [NADX] +0.24%
http://www.biohealthinvestor.com/
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
